Clairity logo

AI Image-based Risk Now Available in Luminary Risk

Now available in Luminary Risk:
Clairity Breast, the first and only FDA-authorized, AI image-based risk assessment for breast cancer.

AI Image-based Risk Now Available in Luminary Risk

ACR & SBI Rebuff New ACP Guidelines

ACR & SBI Rebuff the ACP’s New Breast Cancer Guidelines

The American College of Radiology (ACR) and Society of Breast Imaging (SBI) recently rebuffed the new breast cancer screening guidelines as outlined by the American College of Physicians (ACP). In one of their statements, the ACP now recommends that patients seek biennial screening starting at age 50, instead of annual screening starting at age 40. […]

EQUIP: FDA to Start Issuing Repeat Citations

The EQUIP initiative is in its third year, with 2017 being an educational year, and 2018 marking the first year citations were issued for violations. This year, the FDA will start issuing repeat Level 2 Citations for sites that fail to meet the criteria outlined by the program.

New Illinois Breast Density Legislation!

New Illinois Breast Density Legislation! Effective January 1, 2019, all facilities performing mammograms are required to notify patients of their breast density if they have heterogeneously dense or extremely dense breast tissue.

MagView’s Texting Module

Over 95% of your patients own a cellphone. You will find one in nearly every purse, handbag, and pocket these days.

MagView Help Center Serving National and US Businesses

MagView will soon be going live with our newest support tool, the MagView Help Center, powered by FreshDesk. While this means a great deal for our Support team on the back end, what does this mean for our customers?

Tyrer Cuzick Version 8 is Here!

The newest version of Tyrer–Cuzick, version 8, was released earlier this year in March. This new version is now supported in the latest builds of MagView 7.2 and MagView Luminary.

Request a Demo